Dr. Birendra Singh, President & Global Quality Head, Mankind Pharma
Having an inspirational approach to lead, Dr. Birendra brings over two decades of experience across pharma and healthcare industry. He has a proven track record of excellence and is recognized for setting strategies of quality cultural transformations to achieve global compliance along with sustained growth. Currently, he is in a strategic role in Global Quality, Pharmacovigilance, IT Compliance at Mankind Group. Prior to this, he is known to have led global transformation programs & initiatives in Cipla, Torrent, Zydus, Intas and Mankind at enterprise level.
In an exclusive interaction with Mandvi Singh, Managing Editor, siliconindia, Dr. Birendra Singh, President & Global Quality Head, Mankind Pharma Ltd. sheds light on ‘Navigating Global Compliance in Pharma to Ensure Quality and Sustainability’
Data integrity is essential in the pharmaceutical industry, ensuring the quality, safety, and efficacy of drugs. Since medications can have both beneficial and harmful effects, it’s crucial that they meet high standards throughout their lifecycle, including development, manufacturing, and discontinuation. Accurate documentation during product development is vital to avoid the release of unsafe or ineffective products.
Effective technology transfer is necessary for sharing knowledge between development and manufacturing, which should be welldocumented for future reference, including corrective actions. Maintaining data integrity during commercialization is critical as each batch can affect thousands of patients, and any breaches can jeopardize safety.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
JIO, NOKIA, AMD & CISCO LAUNCH AI-POWERED PLATFORM TO TRANSFORM TELECOM
Jio Platforms, together with Nokia, AMD, and Cisco, has introduced an open AI platform that will change the face of the telecom industry.
HOW TECHNOLOGY IS HELPING MITIGATE CRITICAL CHALLENGES AROUND ENERGY MANAGEMENT & OPTIMIZATION
In a recent interaction with M R Yuvatha, Senior Correspondent, siliconindia, Gaurav Burman, shared his insights on ’How Technology Is Helping Mitigate Critical Challenges around Energy Management and Optimization’.
HOW CUSTOM SOFTWARE DEVELOPMENT IS SHAPING THE FUTURE OF BUSINESS
In a recent interaction with M R Yuvatha, Senior Correspondent at Siliconindia, Ripul Chhabra, shared his insights on 'How Custom Software Development is Shaping the Future of Business’.
5K CAR CARE
DRIVING THE AUTO FRANCHISE SPACE WITH A COMPREHENSIVE APPROACH TO CAR DETAILING
MISSING INSURANCE IN INDIA
Financial literacy and financial inclusion are amongst key factors reflecting any economy's development stage.
JUST AUTO: EQUIPPING MECHANICS WITH ADVANCED TRAINING FOR NEW AGE AUTOMOTIVE SYSTEMS
The Automobile Industry in India is expected to reach $137.06 billion in 2025 and grow at a CAGR of 8.20 percent to reach $203.25 billion by 2030, according to Mordor Intelligence.
NAVIGATING GLOBAL COMPLIANCE IN PHARMA TO ENSURE QUALITY & SUSTAINABILITY
How can pharmaceutical companies establish and maintain robust data integrity practices to ensure regulatory compliance and product quality throughout drug development and manufacturing processes?
CAN INDIA'S EXPANDING GULF PARTNERSHIPS RESHAPE THE WORLD ECONOMY?
India, a nation renowned for its rich cultural heritage and rapidly growing economy, has recently taken a significant step in strengthening its international relations.
GSS SCHOOL OF MUSIC:
Bridging Hobby and Career through Dedicated Music Training
HOW THE PHARMACEUTICAL SECTOR IS EMBRACING SUSTAINABILITY
India's pharmaceutical landscape has evolved rapidly, transforming into a global manufacturing hub with significant exports, especially in generics and vaccines.
